Edwards Lifesciences (EW) Non-Current Deferred Tax Liability (2009 - 2010)
Edwards Lifesciences' (EW) quarterly Non-Current Deferred Tax Liability came in at -$21.9 million in Q4 2010, down 16.49% year-on-year from -$26.2 million in Q4 2009, and down 16.49% quarter-over-quarter from -$18.8 million in Q4 2009.
Edwards Lifesciences (EW) Non-Current Deferred Tax Liability (2009 - 2010) Analysis & Trends
Edwards Lifesciences' Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at -$21.9 million for Q4 2010.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 16.49% year-over-year to -$21.9 million in Q4 2010; TTM through Dec 2010 was -$21.9 million, a 16.49% decrease from a year earlier, with the FY2010 full-year figure at -$21.9 million, down 16.49% from the prior year.
- Non-Current Deferred Tax Liability fell to -$21.9 million in Q4 2010 per EW's latest filing, from -$18.8 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at -$18.8 million in Q4 2009 and bottomed at -$21.9 million in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | -21.90 Mn |
| Dec 31, 2010 | -21.90 Mn |
| Dec 31, 2009 | -18.80 Mn |
| Dec 31, 2009 | -18.80 Mn |